Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2017-2028

2.1.2 B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 B-Cell Maturation Antigen (BCMA) Targeted Therapies Segment by Type

2.2.1 Bispecific Antibodies

2.2.2 Antibody Drug Conjugates

2.2.3 Chimeric Antigen Receptor T-Cells

2.3 B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Type

2.3.1 B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Type (2017-2022)

2.4 B-Cell Maturation Antigen (BCMA) Targeted Therapies Segment by Application

2.4.1 Liver Cancer

2.4.2 Respiratory Cancer

2.4.3 Brain Cancer

2.4.4 Others

2.5 B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Application

2.5.1 B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Application (2017-2022)

3 B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Player

3.1 B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Players

3.1.1 Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue by Players (2020-2022)

3.1.2 Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue Market Share by Players (2020-2022)

3.2 Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 B-Cell Maturation Antigen (BCMA) Targeted Therapies by Regions

4.1 B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Regions (2017-2022)

4.2 Americas B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Growth (2017-2022)

4.3 APAC B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Growth (2017-2022)

4.4 Europe B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Growth (2017-2022)

4.5 Middle East & Africa B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Growth (2017-2022)

5 Americas

5.1 Americas B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Country (2017-2022)

5.2 Americas B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Type (2017-2022)

5.3 Americas B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Region (2017-2022)

6.2 APAC B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Type (2017-2022)

6.3 APAC B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe B-Cell Maturation Antigen (BCMA) Targeted Therapies by Country (2017-2022)

7.2 Europe B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Type (2017-2022)

7.3 Europe B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa B-Cell Maturation Antigen (BCMA) Targeted Therapies by Region (2017-2022)

8.2 Middle East & Africa B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Type (2017-2022)

8.3 Middle East & Africa B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Forecast

10.1 Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast by Regions (2023-2028)

10.1.1 Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast by Regions (2023-2028)

10.1.2 Americas B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast

10.1.3 APAC B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast

10.1.4 Europe B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast

10.1.5 Middle East & Africa B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast

10.2 Americas B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast by Country (2023-2028)

10.2.1 United States B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Forecast

10.2.2 Canada B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Forecast

10.2.3 Mexico B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Forecast

10.2.4 Brazil B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Forecast

10.3 APAC B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast by Region (2023-2028)

10.3.1 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Forecast

10.3.2 Japan B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Forecast

10.3.3 Korea B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Forecast

10.3.4 Southeast Asia B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Forecast

10.3.5 India B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Forecast

10.3.6 Australia B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Forecast

10.4 Europe B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast by Country (2023-2028)

10.4.1 Germany B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Forecast

10.4.2 France B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Forecast

10.4.3 UK B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Forecast

10.4.4 Italy B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Forecast

10.4.5 Russia B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Forecast

10.5 Middle East & Africa B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast by Region (2023-2028)

10.5.1 Egypt B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Forecast

10.5.2 South Africa B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Forecast

10.5.3 Israel B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Forecast

10.5.4 Turkey B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Forecast

10.5.5 GCC Countries B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Forecast

10.6 Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast by Type (2023-2028)

10.7 Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Transposagen Biopharmaceuticals

11.1.1 Transposagen Biopharmaceuticals Company Information

11.1.2 Transposagen Biopharmaceuticals B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered

11.1.3 Transposagen Biopharmaceuticals B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Transposagen Biopharmaceuticals Main Business Overview

11.1.5 Transposagen Biopharmaceuticals Latest Developments

11.2 Sutro Biopharma

11.2.1 Sutro Biopharma Company Information

11.2.2 Sutro Biopharma B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered

11.2.3 Sutro Biopharma B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Sutro Biopharma Main Business Overview

11.2.5 Sutro Biopharma Latest Developments

11.3 Malin Corporation

11.3.1 Malin Corporation Company Information

11.3.2 Malin Corporation B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered

11.3.3 Malin Corporation B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Malin Corporation Main Business Overview

11.3.5 Malin Corporation Latest Developments

11.4 Eureka Therapeutics

11.4.1 Eureka Therapeutics Company Information

11.4.2 Eureka Therapeutics B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered

11.4.3 Eureka Therapeutics B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Eureka Therapeutics Main Business Overview

11.4.5 Eureka Therapeutics Latest Developments

11.5 firstVentury Equity

11.5.1 firstVentury Equity Company Information

11.5.2 firstVentury Equity B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered

11.5.3 firstVentury Equity B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 firstVentury Equity Main Business Overview

11.5.5 firstVentury Equity Latest Developments

11.6 Five Prime Therapeutics

11.6.1 Five Prime Therapeutics Company Information

11.6.2 Five Prime Therapeutics B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered

11.6.3 Five Prime Therapeutics B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Five Prime Therapeutics Main Business Overview

11.6.5 Five Prime Therapeutics Latest Developments

11.7 Credit Suisse Securities

11.7.1 Credit Suisse Securities Company Information

11.7.2 Credit Suisse Securities B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered

11.7.3 Credit Suisse Securities B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Credit Suisse Securities Main Business Overview

11.7.5 Credit Suisse Securities Latest Developments

11.8 Dana-Farber Cancer Institute

11.8.1 Dana-Farber Cancer Institute Company Information

11.8.2 Dana-Farber Cancer Institute B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered

11.8.3 Dana-Farber Cancer Institute B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Dana-Farber Cancer Institute Main Business Overview

11.8.5 Dana-Farber Cancer Institute Latest Developments

11.9 Deerfield Partners

11.9.1 Deerfield Partners Company Information

11.9.2 Deerfield Partners B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered

11.9.3 Deerfield Partners B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Deerfield Partners Main Business Overview

11.9.5 Deerfield Partners Latest Developments

11.10 Onyx Pharmaceuticals

11.10.1 Onyx Pharmaceuticals Company Information

11.10.2 Onyx Pharmaceuticals B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered

11.10.3 Onyx Pharmaceuticals B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Onyx Pharmaceuticals Main Business Overview

11.10.5 Onyx Pharmaceuticals Latest Developments

11.11 Juno Therapeutics

11.11.1 Juno Therapeutics Company Information

11.11.2 Juno Therapeutics B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered

11.11.3 Juno Therapeutics B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Juno Therapeutics Main Business Overview

11.11.5 Juno Therapeutics Latest Developments

12 Research Findings and Conclusion

Table 1. B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Bispecific Antibodies

Table 3. Major Players of Antibody Drug Conjugates

Table 4. Major Players of Chimeric Antigen Receptor T-Cells

Table 5. B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 6. Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Type (2017-2022) & ($ Millions)

Table 7. Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Type (2017-2022)

Table 8. B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Application (2017-2022) & ($ Millions)

Table 10. Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Application (2017-2022)

Table 11. Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue by Players (2020-2022) & ($ Millions)

Table 12. Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue Market Share by Player (2020-2022)

Table 13. B-Cell Maturation Antigen (BCMA) Targeted Therapies Key Players Head office and Products Offered

Table 14. B-Cell Maturation Antigen (BCMA) Targeted Therapies Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Regions 2017-2022 & ($ Millions)

Table 18. Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Regions (2017-2022)

Table 19. Americas B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Country (2017-2022) & ($ Millions)

Table 20. Americas B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Country (2017-2022)

Table 21. Americas B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Type (2017-2022) & ($ Millions)

Table 22. Americas B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Type (2017-2022)

Table 23. Americas B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Application (2017-2022) & ($ Millions)

Table 24. Americas B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Application (2017-2022)

Table 25. APAC B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Region (2017-2022) & ($ Millions)

Table 26. APAC B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Region (2017-2022)

Table 27. APAC B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Type (2017-2022) & ($ Millions)

Table 28. APAC B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Type (2017-2022)

Table 29. APAC B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Application (2017-2022) & ($ Millions)

Table 30. APAC B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Application (2017-2022)

Table 31. Europe B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Country (2017-2022) & ($ Millions)

Table 32. Europe B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Country (2017-2022)

Table 33. Europe B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Type (2017-2022) & ($ Millions)

Table 34. Europe B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Type (2017-2022)

Table 35. Europe B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Application (2017-2022) & ($ Millions)

Table 36. Europe B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Application (2017-2022)

Table 37. Middle East & Africa B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Region (2017-2022) & ($ Millions)

Table 38. Middle East & Africa B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Region (2017-2022)

Table 39. Middle East & Africa B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Type (2017-2022) & ($ Millions)

Table 40. Middle East & Africa B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Type (2017-2022)

Table 41. Middle East & Africa B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size by Application (2017-2022) & ($ Millions)

Table 42. Middle East & Africa B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Application (2017-2022)

Table 43. Key Market Drivers & Growth Opportunities of B-Cell Maturation Antigen (BCMA) Targeted Therapies

Table 44. Key Market Challenges & Risks of B-Cell Maturation Antigen (BCMA) Targeted Therapies

Table 45. Key Industry Trends of B-Cell Maturation Antigen (BCMA) Targeted Therapies

Table 46. Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 47. Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share Forecast by Regions (2023-2028)

Table 48. Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 49. Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share Forecast by Type (2023-2028)

Table 50. Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 51. Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share Forecast by Application (2023-2028)

Table 52. Transposagen Biopharmaceuticals Details, Company Type, B-Cell Maturation Antigen (BCMA) Targeted Therapies Area Served and Its Competitors

Table 53. Transposagen Biopharmaceuticals B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered

Table 54. Transposagen Biopharmaceuticals B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 55. Transposagen Biopharmaceuticals Main Business

Table 56. Transposagen Biopharmaceuticals Latest Developments

Table 57. Sutro Biopharma Details, Company Type, B-Cell Maturation Antigen (BCMA) Targeted Therapies Area Served and Its Competitors

Table 58. Sutro Biopharma B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered

Table 59. Sutro Biopharma Main Business

Table 60. Sutro Biopharma B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 61. Sutro Biopharma Latest Developments

Table 62. Malin Corporation Details, Company Type, B-Cell Maturation Antigen (BCMA) Targeted Therapies Area Served and Its Competitors

Table 63. Malin Corporation B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered

Table 64. Malin Corporation Main Business

Table 65. Malin Corporation B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. Malin Corporation Latest Developments

Table 67. Eureka Therapeutics Details, Company Type, B-Cell Maturation Antigen (BCMA) Targeted Therapies Area Served and Its Competitors

Table 68. Eureka Therapeutics B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered

Table 69. Eureka Therapeutics Main Business

Table 70. Eureka Therapeutics B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. Eureka Therapeutics Latest Developments

Table 72. firstVentury Equity Details, Company Type, B-Cell Maturation Antigen (BCMA) Targeted Therapies Area Served and Its Competitors

Table 73. firstVentury Equity B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered

Table 74. firstVentury Equity Main Business

Table 75. firstVentury Equity B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. firstVentury Equity Latest Developments

Table 77. Five Prime Therapeutics Details, Company Type, B-Cell Maturation Antigen (BCMA) Targeted Therapies Area Served and Its Competitors

Table 78. Five Prime Therapeutics B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered

Table 79. Five Prime Therapeutics Main Business

Table 80. Five Prime Therapeutics B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. Five Prime Therapeutics Latest Developments

Table 82. Credit Suisse Securities Details, Company Type, B-Cell Maturation Antigen (BCMA) Targeted Therapies Area Served and Its Competitors

Table 83. Credit Suisse Securities B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered

Table 84. Credit Suisse Securities Main Business

Table 85. Credit Suisse Securities B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. Credit Suisse Securities Latest Developments

Table 87. Dana-Farber Cancer Institute Details, Company Type, B-Cell Maturation Antigen (BCMA) Targeted Therapies Area Served and Its Competitors

Table 88. Dana-Farber Cancer Institute B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered

Table 89. Dana-Farber Cancer Institute Main Business

Table 90. Dana-Farber Cancer Institute B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 91. Dana-Farber Cancer Institute Latest Developments

Table 92. Deerfield Partners Details, Company Type, B-Cell Maturation Antigen (BCMA) Targeted Therapies Area Served and Its Competitors

Table 93. Deerfield Partners B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered

Table 94. Deerfield Partners Main Business

Table 95. Deerfield Partners B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 96. Deerfield Partners Latest Developments

Table 97. Onyx Pharmaceuticals Details, Company Type, B-Cell Maturation Antigen (BCMA) Targeted Therapies Area Served and Its Competitors

Table 98. Onyx Pharmaceuticals B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered

Table 99. Onyx Pharmaceuticals Main Business

Table 100. Onyx Pharmaceuticals B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 101. Onyx Pharmaceuticals Latest Developments

Table 102. Juno Therapeutics Details, Company Type, B-Cell Maturation Antigen (BCMA) Targeted Therapies Area Served and Its Competitors

Table 103. Juno Therapeutics B-Cell Maturation Antigen (BCMA) Targeted Therapies Product Offered

Table 104. Juno Therapeutics B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 105. Juno Therapeutics Main Business

Table 106. Juno Therapeutics Latest Developments

List of Figures

Figure 1. B-Cell Maturation Antigen (BCMA) Targeted Therapies Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Type in 2021

Figure 7. B-Cell Maturation Antigen (BCMA) Targeted Therapies in Liver Cancer

Figure 8. Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market: Liver Cancer (2017-2022) & ($ Millions)

Figure 9. B-Cell Maturation Antigen (BCMA) Targeted Therapies in Respiratory Cancer

Figure 10. Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market: Respiratory Cancer (2017-2022) & ($ Millions)

Figure 11. B-Cell Maturation Antigen (BCMA) Targeted Therapies in Brain Cancer

Figure 12. Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market: Brain Cancer (2017-2022) & ($ Millions)

Figure 13. B-Cell Maturation Antigen (BCMA) Targeted Therapies in Others

Figure 14. Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market: Others (2017-2022) & ($ Millions)

Figure 15. Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Application in 2021

Figure 16. Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue Market Share by Player in 2021

Figure 17. Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Regions (2017-2022)

Figure 18. Americas B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2017-2022 ($ Millions)

Figure 19. APAC B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2017-2022 ($ Millions)

Figure 20. Europe B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2017-2022 ($ Millions)

Figure 22. Americas B-Cell Maturation Antigen (BCMA) Targeted Therapies Value Market Share by Country in 2021

Figure 23. Americas B-Cell Maturation Antigen (BCMA) Targeted Therapies Consumption Market Share by Type in 2021

Figure 24. Americas B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Application in 2021

Figure 25. United States B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Region in 2021

Figure 30. APAC B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Application in 2021

Figure 31. China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Growth 2017-2022 ($ Millions)

Figure 35. India B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Country in 2021

Figure 38. Europe B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Type in 2021

Figure 39. Europe B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Application in 2021

Figure 40. Germany B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Growth 2017-2022 ($ Millions)

Figure 41. France B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Market Share by Application in 2021

Figure 48. Egypt B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2023-2028 ($ Millions)

Figure 54. APAC B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2023-2028 ($ Millions)

Figure 55. Europe B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2023-2028 ($ Millions)

Figure 57. United States B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2023-2028 ($ Millions)

Figure 58. Canada B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2023-2028 ($ Millions)

Figure 59. Mexico B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2023-2028 ($ Millions)

Figure 60. Brazil B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2023-2028 ($ Millions)

Figure 61. China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2023-2028 ($ Millions)

Figure 62. Japan B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2023-2028 ($ Millions)

Figure 63. Korea B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2023-2028 ($ Millions)

Figure 65. India B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2023-2028 ($ Millions)

Figure 66. Australia B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2023-2028 ($ Millions)

Figure 67. Germany B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2023-2028 ($ Millions)

Figure 68. France B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2023-2028 ($ Millions)

Figure 69. UK B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2023-2028 ($ Millions)

Figure 70. Italy B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2023-2028 ($ Millions)

Figure 71. Russia B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2023-2028 ($ Millions)

Figure 72. Spain B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2023-2028 ($ Millions)

Figure 73. Egypt B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2023-2028 ($ Millions)

Figure 74. South Africa B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2023-2028 ($ Millions)

Figure 75. Israel B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2023-2028 ($ Millions)

Figure 76. Turkey B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size 2023-2028 ($ Millions)